|Bid||217.99 x 1100|
|Ask||233.04 x 800|
|Day's Range||223.98 - 231.30|
|52 Week Range||143.90 - 284.86|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||54.26|
|Earnings Date||Apr 26, 2021 - Apr 30, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 23, 2012|
|1y Target Est||297.83|
The Zacks Analyst Blog Highlights: Abbott, Johnson & Johnson, Masimo Corp and Medtronic
Masimo provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety, including SET® pulse oximetry.
These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.